Login / Signup

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.

Gabriela Athziri Sánchez-ZunoMónica Guadalupe Matuz-FloresGuillermo González-EstevezFerdinando NicolettiFrancisco Javier Turrubiates-HernándezKatia ManganoJosé Francisco Munoz-Valle
Published in: International journal of immunopathology and pharmacology (2021)
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents an unprecedented global public health emergency with economic and social consequences. One of the main concerns in the development of vaccines is the antibody-dependent enhancement phenomenon, better known as ADE. In this review, we provide an overview of SARS-CoV-2 infection as well as the immune response generated by the host. On the bases of this principle, we also describe what is known about the ADE phenomenon in various viral infections and its possible role as a limiting factor in the development of new vaccines and therapeutic strategies.
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • public health
  • immune response
  • healthcare
  • emergency department
  • inflammatory response
  • toll like receptor
  • low cost
  • emergency medical